Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

184.02 +2.34 (+1.29%)
Official Closing Price Updated: 7:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
80 81 Next >
Prediction: Eli Lilly's Latest Move Will Threaten AbbVie Stock
It'll be a while before there's any impact, but it could be a big deal. 
Via The Motley Fool
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
Drug companies are investing in schizophrenia treatments as patients are desperate for a drug that has few side effects, Bloomberg reports. 
Via Benzinga
AbbVie Unusual Options Activity For August 26
Via Benzinga
Donald Trump Owns These 21 Dividend Kings. Should You?
Some of Trump's Dividend Kings deserve a crown more than others. 
Via The Motley Fool
Topics Government
Exposures Political
3 Unstoppable Dividend Stocks to Buy Right Now
These stocks are the A-team for income investors. 
Via The Motley Fool
Key Takeaways From AbbVie Analyst Ratings
Via Benzinga
Unpacking the Latest Options Trading Trends in AbbVie
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
Via Benzinga
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
Analysts expect Novo Nordisk's Ozempic and other major drugs to be included in 2027 Medicare price negotiations. Despite concerns, experts predict limited financial impact on companies like Pfizer,... 
Via Benzinga
How To Build A Dividend Growth Portfolio In An Overpriced Market
The stock market as measured by the S&P is currently at an all-time high which makes it very challenging to try to build a quality dividend growth portfolio. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Biotech Bull Market: 3 Ways To Play It
Although we are in the later stages of this bull market a cut in interest rates by the Fed should help biotech as you have seen from the recent rally. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
3 High-Yield Stocks to Buy Now That Have Increased Their Dividends for 25 Years or More
These stocks dividends continue to flow and grow. 
Via The Motley Fool
These 3 Healthcare Companies Had the Top-Selling Drugs Last Year
This list of top-selling drugs could look drastically different in a few years. 
Via The Motley Fool
Decoding AbbVie's Options Activity: What's the Big Picture?
Via Benzinga
Botox Innovator Revance Therapeutics Goes Private In Over $900M Deal
Crown Laboratories will acquire Revance Therapeutics for $924 million, paying $6.66 per share — a premium of 89%. 
Via Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
Via Benzinga
3 High-Yielding Dividend Growth Stocks That Retirees Can Rely On for Recurring Income
These stocks all pay more than 3%, and they have been regularly increasing their payouts in recent years. 
Via The Motley Fool
Lock in Gains: 3 Dividend Stocks Poised to Boost Payouts Soon
These three stocks have a long history of increasing their dividends and are likely to benefit from sector rotation on expectations of lower interest rates 
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
The 3 Best Stocks to Buy to Survive Another S&P 500 Crash
These three stocks to buy now will protect your portfolio if the S&P 500 crashes again regardless of whether there is a recession or not. 
Via InvestorPlace
Topics Economy Stocks
Exposures Economy US Equities
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
Syros Pharmaceuticals announces discontinuing enrollment in the SELECT-AML-1 Phase 2 trial due to the low probability of demonstrating superiority. The trial evaluated tamibarotene with venetoclax and... 
Via Benzinga
3 Stocks Retirees Should Absolutely Love
All of these stocks can provide steady income to retired investors. 
Via The Motley Fool
As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032
EQNX::TICKER_START (NYSE:OGEN),(NYSE:ABT),(NASDAQ:BIIB),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END 
Via FinancialNewsMedia
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
The market has been a rollercoaster lately, with the resilience of defensive sectors and the modest bounce in the technology sector painting an intriguing picture. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Warren Buffett's Approach To Investing In Election Years
Warren Buffett, known as the 'Oracle of Omaha', is a highly successful American investor who manages his portfolio consistently, regardless of elections or market conditions. 
Via Benzinga
Elliott Wave Technical Analysis: AbbVie Inc.
An in-depth look at ABBV's price movements using the Elliott Wave Theory, helping traders identify potential opportunities based on current trends and market structure. 
Via Talk Markets
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment
New research suggests that powerful magnets could effectively treat bipolar disorder. This therapy, which is known as accelerated intermittent theta burst stimulation (iTBS), uses magnetic waves... 
Via PressReach
Exposures Product Safety
AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
Via Benzinga
Large Cap Biopharma And Healthcare, A Port In A Storm
Healthcare and biopharma show nice gains in a volatile week. 
Via Talk Markets
Worried About a Market Correction? 2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever.
Recent market pressure could worsen, but that won't stop these successful businesses from raising their dividend payouts. 
Via The Motley Fool
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
80 81 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.